Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a psychotic disorder or a related mental health condition (such as affective or non-affective psychosis)
- People who are currently being seen and treated by a clinician at one of the participating services
- People whose symptoms are stable enough, and who are able to use online platforms and take part in group sessions, as determined by their psychiatrist or case manager
- People who have access to a private space, such as a room where they can be alone, to keep group sessions confidential
- People who are able to provide an emergency contact and agree to allow researchers to contact their clinician and/or emergency services if needed during the study
Who may not be able to join:
- People who have an intellectual disability
- People who are currently hospitalised at the time of recruitment
- People who are unable to speak or read English or French
- People who are assessed as being at high risk of suicide at the time of evaluation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Martin Lepage, Douglas Mental Health University Institute
Phone: (514) 761-6131
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline Brief version of the Cambridge Neuropsychological Testing Automated Battery (CANTAB) score at the end of the intervention; Change from Baseline Wechsler Memory Scale - Logical Memory (LM) subscale score at the end of the intervention; Change from Baseline Brief Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS-B) score at the end of the intervention; Change from Baseline Cognitive Motivation Scale (CMS) score at the end of the intervention; Change from Baseline Davos Assessment of Cognitive Biases Scale (DACOBS) score at the end of the intervention; Change...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.